Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents

Summary

This study is a randomized, double-blinded, placebo-controlled, phase Ⅱb clinical trial of an inactivated SARS-CoV-2 vaccine (CoronaVac) manufactured by Sinovac Life Sciences Co. , Ltd.The purpose of this study is to evaluate the safety of the SARS-CoV-2 Inactivated vaccine in healthy children and adolescents aged 3-17 years.

Timeline

Start

2021-05-03

Primary completion

2021-08-01

Completion

2022-06-20

Drugs

Indications